Bin Tean Teh

Active 1992–2025

Also published as
Bin-Tean Teh
210
Papers
41,033
Citations
108
h-index
199
i10-index

Citations

Citations per year for Bin Tean Teh1971: 1 citations1984: 1 citations1992: 1 citations1993: 3 citations1994: 2 citations1996: 4 citations1997: 15 citations1998: 43 citations1999: 26 citations2000: 61 citations2001: 60 citations2002: 63 citations2003: 97 citations2004: 134 citations2005: 147 citations2006: 210 citations2007: 226 citations2008: 271 citations2009: 285 citations2010: 355 citations2011: 463 citations2012: 513 citations2013: 557 citations2014: 563 citations2015: 457 citations2016: 445 citations2017: 457 citations2018: 364 citations2019: 1,259 citations2020: 1,542 citations2021: 1,498 citations2022: 1,196 citations2023: 934 citations2024: 1,350 citations2025: 623 citations2026: 22 citations1972–1983: no citations, so these years are not shown1985–1991: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,297 citing papers, 26% of this breakdownChina: 2,407 citing papers, 11.8% of this breakdownUnited Kingdom: 1,518 citing papers, 7.4% of this breakdownGermany: 939 citing papers, 4.6% of this breakdownItaly: 857 citing papers, 4.2% of this breakdownFrance: 787 citing papers, 3.9% of this breakdownJapan: 772 citing papers, 3.8% of this breakdownCanada: 691 citing papers, 3.4% of this breakdownNetherlands: 532 citing papers, 2.6% of this breakdownSpain: 504 citing papers, 2.5% of this breakdownAustralia: 496 citing papers, 2.4% of this breakdownSingapore: 412 citing papers, 2% of this breakdown
0%26%Other 25.4%

Fields

  • Biochemistry, Genetics and Molecular Biology48%
  • Medicine45.3%
  • Immunology and Microbiology2.3%
  • Agricultural and Biological Sciences1.2%
  • Computer Science0.6%
  • Neuroscience0.5%
  • Other2.1%

Topics

  • Cancer Genomics and Diagnostics6%
  • Epigenetics and DNA Methylation3.8%
  • Renal cell carcinoma treatment2.6%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.3%
  • RNA modifications and cancer2.3%
  • Cancer, Hypoxia, and Metabolism1.9%
  • Other81.1%

Coauthors

All papers

Open in search
  1. The repertoire of mutational signatures in human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , S. M. Ashiqul Islam, Marat D. Kazanov, Jaegil Kim, Leszek J. Klimczak, Núria López-Bigas, Michael S. Lawrence, Iñigo Martincorena, John R. McPherson, Sandro Morganella, Ville Mustonen, Hidewaki Nakagawa, Alvin Wei Tian Ng, Paz Polak, Stephenie D. Prokopec, Steven A. Roberts, Steve Rozen, Radhakrishnan Sabarinathan, Natalie Saini, Tatsuhiro Shibata, Yuichi Shiraishi, Michael R. Stratton, Bin Tean Teh, Ignacio Vázquez-Garćıa, David A. Wheeler, Yang Wu, Fouad Yousif, Willie Yu, Gad Getz, Steven G. Rozen, Michael R. Stratton, Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams, Nishant Agrawal, Keun Soo Ahn, Sung‐Min Ahn, Hiroshi Aikata, Rehan Akbani, Kadir C. Akdemir, Hikmat Al‐Ahmadie, Sultan T. Al‐Sedairy, Fátima Al‐Shahrour, Malik Alawi, Monique Albert, Kenneth Aldape, Ludmil B. Alexandrov, Adrian Ally, Kathryn Alsop, Eva G. Álvarez, Fernanda Amary, Samirkumar B. Amin, Brice Aminou, Ole Ammerpohl, Matthew J. Anderson, Yeng Ang, Davide Antonello, Pavana Anur, Samuel Aparício, Elizabeth L. Appelbaum, Yasuhito Arai, Axel Aretz, Koji Arihiro, Shun‐ichi Ariizumi, Joshua Armenia, Laurent Arnould, L. Sylvia, Yassen Assenov, Gurnit Atwal and 1,284 more - Nature 2020 cited by 3,816

  2. Cholangiocarcinoma

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2021 cited by 841

  3. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasushi Totoki, Hiromi Nakamura, Yasuhito Arai, Satoshi Yamasaki, Pierce K. H. Chow, Alexander Yaw Fui Chung, London Lucien Ooi, Kiat Hon Lim, Simona Dima, Dan G. Duda, Irinel Popescu, Philippe Broët, Sen‐Yung Hsieh, Ming‐Chin Yu, Aldo Scarpa, Jiaming Lai, Dixian Luo, André Lopes Carvalho, André L. Vettore, Hyungjin Rhee, Young Nyun Park, Ludmil B. Alexandrov, Raluca Gordân, Steve Rozen, Tatsuhiro Shibata, Chawalit Pairojkul, Bin Tean Teh, Patrick Tan - Cancer Discovery 2017 cited by 989

  4. Patterns of somatic mutation in human cancer genomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andy Menzies, Tatiana Mironenko, Janet Perry, Keiran Raine, David Richardson, Rebecca Shepherd, Alexandra Small, Calli Tofts, Jennifer Varian, Tony Webb, Sofie West, Sara Widaa, Andy Yates, Daniel P. Cahill, David N. Louis, Peter Goldstraw, Andrew G. Nicholson, Francis Brasseur, Leendert H. J. Looijenga, Barbara L. Weber, Yoke-Eng Chiew, Anna DeFazio, Mel Greaves, Anthony R. Green, Peter J. Campbell, Ewan Birney, Douglas F. Easton, Georgia Chenevix‐Trench, Min-Han Tan, Sok Kean Khoo, Bin Tean Teh, Siu Tsan Yuen, Suet Yi Leung, Richard Wooster, P. Andrew Futreal, Michael R. Stratton - Nature 2007 cited by 3,147

  5. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack A. Taylor, D Neil Hayes, David Malkin, ICGC Breast Cancer Group, ICGC Chronic Myeloid Disorders Group, ICGC Prostate Cancer Group, Christopher S. Foster, Anne Y. Warren, Hayley C. Whitaker, Daniel S. Brewer, Rosalind A. Eeles, Colin Cooper, David E. Neal, Tapio Visakorpi, William B. Isaacs, G. Steven Bova, Adrienne M. Flanagan, P. Andrew Futreal, Andy G. Lynch, Patrick F. Chinnery, Ultan McDermott, Michael R. Stratton, Peter J. Campbell - eLife 2014 cited by 500

  6. Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2018 cited by 321

  7. Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xin Wei Wang, Hidewaki Nakagawa, Mu‐Sheng Zeng, Fan Bai, Ning Zhang - Cancer Cell 2019 cited by 298

  8. Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wai Ming Yap, Ming Teh, Khay Guan Yeoh, Patrick Tan - Cancer Cell 2017 cited by 328

  9. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laurence de Leval, Joseph M. Connors, Jamés O. Armitage, Julie M. Vose, Wing C. Chan, Louis M. Staudt - Blood 2014 cited by 540

  10. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2017 cited by 378

  11. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David A. Tuveson, Pedro A. Pérez–Mancera, Ville Mustonen, Andrej Fischer, David J. Adams, Alistair G. Rust, Waraporn Chan-on, Chutima Subimerb, Karl Dykema, Kyle Furge, Peter J. Campbell, Bin Tean Teh, Michael R. Stratton, P. Andrew Futreal - Nature 2011 cited by 1,291

  12. Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paiboon Sithithaworn, Puangrat Yongvanit, Sopit Wongkham, Narong Khuntikeo, Vajaraphongsa Bhudhisawasdi, Irinel Popescu, Steve Rozen, Patrick Tan, Bin Tean Teh - Nature Genetics 2013 cited by 496

  13. Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-Fluorouracil

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2013 cited by 460

  14. An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , - Cancer Cell 2011 cited by 401

  15. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masao Seto, Andreas Rosenwald, German Ott, Elı́as Campo, Lisa M. Rimsza, Elaine S. Jaffe, Rita M. Braziel, Francesco d’Amore, Giorgio Inghirami, Francesco Bertoni, Laurence de Leval, Philippe Gaulard, Louis M. Staudt, Timothy W. McKeithan, Stefano Pileri, Wing C. Chan, Javeed Iqbal - Blood 2019 cited by 275

  16. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lee Mulderrig, Laura Mudie, Sarah O’Meara, Erin Pleasance, Arjunan Rajasingham, Rebecca Shepherd, Raffaella Smith, Lucy Stebbings, Philip Stephens, Gurpreet Tang, Patrick Tarpey, Kelly Turrell, Karl Dykema, Sok Kean Khoo, David Petillo, Bill Wondergem, John Anema, Richard J. Kahnoski, Bin Tean Teh, Michael R. Stratton, P. Andrew Futreal - Nature 2010 cited by 1,186

  17. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William G. Kaelin, Albert S. Baldwin, Qing Zhang - Science 2018 cited by 221

  18. Intragenic ERBB2 kinase mutations in tumours

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Petty, Keiran Raine, Lewis Ratford, Rebecca Shepherd, Alexandra Small, Yvonne Stephens, Calli Tofts, Jennifer Varian, Sofie West, Sara Widaa, Andrew Yates, Francis Brasseur, Colin S. Cooper, Adrienne M. Flanagan, Margaret A. Knowles, Suet Yi Leung, David N. Louis, Leendert H. J. Looijenga, Bruce Malkowicz, Marco A. Pierotti, Bin Tean Teh, Georgia Chenevix‐Trench, Barbara L. Weber, Siu Tsan Yuen, Grace Harris, Peter Goldstraw, Andrew G. Nicholson, P. Andrew Futreal, Richard Wooster, Michael R. Stratton - Nature 2004 cited by 792

  19. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2022 cited by 48

  20. Exome sequencing of liver fluke–associated cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Puangrat Yongvanit, P. Andrew Futreal, Vajarabhongsa Bhudhisawasdi, Steve Rozen, Patrick Tan, Bin Tean Teh - Nature Genetics 2012 cited by 493

  21. In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors

    Authors: , , , , , , , , , - Genome Research 2018 cited by 192

  22. Abscisic acid perception and signaling: structural mechanisms and applications

    Authors: , , , - Acta Pharmacologica Sinica 2014 cited by 243

  23. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient

    Authors: , , , , , , , , , , , , , , , - Human Cell 2020 cited by 128

  24. Signatures of mutation and selection in the cancer genome

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2010 cited by 726